Latest & greatest articles for autism

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on autism or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on autism and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Autism

Autism is a neurodevelopmental disorder (a type of mental disorder) characterised by difficult social interaction, impaired communication (both verbal and non-verbal), and restricted and repetitive behaviours. It forms part of the broader autism spectrum disorder (ASD), a range of similar conditions, including Asperger syndrome.

Autism is a condition that begins from early childhood and is often suspected and diagnosed by ages 1-3. It is a lifelong disability that affects how people interact with others.

Autism causes and treatment

There have been many misconceptions as to what causes autism in the past such as the MMR vaccine and diet. Extensive research and clinical trials have concluded that none of these factors cause autism or ASD. However, the real cause is little understood but research is starting to unpick potential factors such as genetics, pollution and other environmental factors. A current favoured idea is that genes inherited from a child’s parents can make them more vulnerable to developing autism, some researchers suggest that the disorder will only develop when triggered by environmental factors.

The exact cause of autism spectrum disorder is unknown, however research into the disorder suggest that it is caused by several genetic and environmental factors. Genes inherited from a child’s parents can make them more vulnerable to developing autism, some researchers suggest that the disorder will only develop when triggered by environmental factors. Read more in clinical papers on autism.

Autism can be managed with a combination of prescribed medicines and behavioural treatment, depending on the severity of the disorder. Read about clinical trials and medical advancements for the treatment of autism on Trip.

Hot topics in Trip

Users of Trip frequently look at topics around adolescents, therapies, behaviour and screening. They also explore such topics as omega-3 fatty acids, SSRIs and aripiprazole. All these topics, and more, can be easily searched for within Trip.

Top results for autism

141. [Biomedical treatment and diet supplements for the treatment of the autism spectrum disorder]

[Biomedical treatment and diet supplements for the treatment of the autism spectrum disorder] Tratamiento biomédico y suplementos alimentarios para el tratamiento del espectro autista [Biomedical treatment and diet supplements for the treatment of the autism spectrum disorder] Tratamiento biomédico y suplementos alimentarios para el tratamiento del espectro autista [Biomedical treatment and diet supplements for the treatment of the autism spectrum disorder] Pichon Riviere A, Augustovski F (...) espectro autista. [Biomedical treatment and diet supplements for the treatment of the autism spectrum disorder] Buenos Aires: Institute for Clinical Effectiveness and Health Policy (IECS). Informe de Respuesta Rápida N° 261. 2012 Authors' objectives To assess the available evidence on the efficacy, safety and issues related to coverage policies for the use of biomedical treatment and food supplements in patients with autism spectrum disorder. Authors' conclusions "Biomedical treatment" has not been

Health Technology Assessment (HTA) Database.2012

142. 2.64% of South Korean children aged 7 to 12 have autism spectrum disorders

2.64% of South Korean children aged 7 to 12 have autism spectrum disorders 2.64% of South Korean children aged 7 to 12 have autism spectrum disorders | Evidence-Based Mental Health This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using (...) your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here 2.64% of South Korean children aged 7 to 12 have autism spectrum disorders Article Text Prevalence 2.64% of South Korean children aged 7 to 12 have autism spectrum disorders Statistics from Altmetric.com No Altmetric data available for this article. Question Question What are the prevalence and clinical characteristics of autism spectrum disorders

Evidence-Based Mental Health2012

144. Interventions for adolescents and young adults with autism spectrum disorders

Interventions for adolescents and young adults with autism spectrum disorders Interventions for adolescents and young adults with autism spectrum disorders Interventions for adolescents and young adults with autism spectrum disorders Lounds Taylor J, Dove D, Veenstra-VanderWeele J, Sathe NA, McPheeters ML, Jerome RN, Warren Z Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been (...) made for the HTA database. Citation Lounds Taylor J, Dove D, Veenstra-VanderWeele J, Sathe NA, McPheeters ML, Jerome RN, Warren Z. Interventions for adolescents and young adults with autism spectrum disorders. Rockville: Agency for Healthcare Research and Quality (AHRQ). Comparative Effectiveness Review No. 65. 2012 Authors' objectives We systematically reviewed evidence on therapies for adolescents and young adults (ages 13 to 30) with autism spectrum disorders (ASD). We focused on the outcomes

Health Technology Assessment (HTA) Database.2012

145. Sibling recurrence rate of autism spectrum disorders is 18.7%

Sibling recurrence rate of autism spectrum disorders is 18.7% Sibling recurrence rate of autism spectrum disorders is 18.7% | Evidence-Based Mental Health This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password (...) For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Sibling recurrence rate of autism spectrum disorders is 18.7% Article Text Aetiology Sibling recurrence rate of autism spectrum disorders is 18.7% Statistics from Altmetric.com No Altmetric data available for this article. Question Question What is the sibling recurrence risk of autism spectrum disorder? People 664 infant siblings (≤18 months) of children with autism spectrum disorders

Evidence-Based Mental Health2012

146. [Efficacy, effectiveness and safety of behavioural interventions in patients with autism spectrum disorders]

[Efficacy, effectiveness and safety of behavioural interventions in patients with autism spectrum disorders] Efectividad de las terapias conductuales en los trastornos del espectro autista [Efficacy, effectiveness and safety of behavioural interventions in patients with autism spectrum disorders] Efectividad de las terapias conductuales en los trastornos del espectro autista [Efficacy, effectiveness and safety of behavioural interventions in patients with autism spectrum disorders] Reza-Goyanes (...) M Citation Reza-Goyanes M. Efectividad de las terapias conductuales en los trastornos del espectro autista. [Efficacy, effectiveness and safety of behavioural interventions in patients with autism spectrum disorders] Unidad de Evaluacion de Tecnologias Sanitarias (UETS). UETS 2011/05. 2012 Authors' conclusions Studies show benefits achieved with some behavioural interventions. But these results must be interpreted with caution because of the absence of results consistency between studies

Health Technology Assessment (HTA) Database.2012

147. Autism in adults: diagnosis and management

Autism in adults: diagnosis and management Autism spectrum disorder in adults: Autism spectrum disorder in adults: diagnosis and management diagnosis and management Clinical guideline Published: 27 June 2012 nice.org.uk/guidance/cg142 © NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline represent the view of NICE, arrived at after careful (...) in a way that would be inconsistent with complying with those duties. Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. Autism spectrum disorder in adults: diagnosis and management (CG142) © NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 2

National Institute for Health and Clinical Excellence - Clinical Guidelines2012

148. Social Skills Groups for People Aged 6 to 21 with Autism Spectrum Disorders (ASD)

Social Skills Groups for People Aged 6 to 21 with Autism Spectrum Disorders (ASD) 404 - The Campbell Collaboration Media Centre Blog Newsletter Sign Up Menu or search for what you are looking for in the search box above Useful Links News and Jobs Twitter Copyright © 2017 Campbell Collaboration. All Rights Reserved

Campbell Collaboration2012

149. Effectiveness of Adult Employment Assistance Services for Persons with Autism Spectrum Disorders

Effectiveness of Adult Employment Assistance Services for Persons with Autism Spectrum Disorders 404 - The Campbell Collaboration Media Centre Blog Newsletter Sign Up Menu or search for what you are looking for in the search box above Useful Links News and Jobs Twitter Copyright © 2017 Campbell Collaboration. All Rights Reserved

Campbell Collaboration2012

150. Autism and PDD - Management for child or teenager

Autism and PDD - Management for child or teenager QUICK REFERENCE GUIDE Autism and other PDDs 1 Coordinated education and treatment interventions in children and adolescents Coordinated education and treatment interventions in children and adolescents March 2012 March 2012 INVOLVE THE CHILD OR ADOLESCENT AND PARENTS – PAY ATTENTION TO SIBLINGS Children and adolescents have rights. They should be treated with dignity and their history, personality, routines, own wishes and tastes, abilities (...) , and then at transitional ages or during transition periods, to ensure that the care plan is consistent with up-to-date diagnosis and knowledge. ? All care teams should be trained in and have access to the following tools: Childhood Autism Rating Scale (CARS), Vineland Adaptive Behaviour Scale (VABS), Échelle des comportements autistiques [Autistic Behaviour Scale] (ECA), Échelle de communication sociale précoce [Early Social Communication Scale] (ESCS), Psychoeducational Profiles (PEP-3 and AAPEP), and standardised

HAS Guidelines2012

151. Autism spectrum disorder ? Speech therapist directed use of video monitoring

Autism spectrum disorder ? Speech therapist directed use of video monitoring Speech Therapy/Autism Spectrum Disorder/Video Modeling/BESt 138 Best Evidence Statement (BESt) Copyright © 2012 Cincinnati Children's Hospital Medical Center; all rights reserved Page 1 of 9 August 22, 2012 Speech Therapist Directed use of Video Modeling for Patients with Autism Spectrum Disorder Clinical Question P (Population/Problem) Among pediatric patients with Autism Spectrum Disorder (ASD) I (Intervention) does (...) with developmental disabilities other than autism, patients unable to attend to audio/visual scenes for less than 1 minute. Recommendation (See Dimensions for Judging the Strength of the Recommendation) It is recommended that speech-language pathologists working with children with autism spectrum disorder incorporate the use of video based modeling into treatment plans to target either functional or imaginative play* skills (Boudreau, 2010 [4b]; Paterson, 2007 [4b]; Hine, 2006 [4b]; Charlop-Christy, 2000 [4b

Cincinnati Children's Hospital Medical Center2012

152. Autism ? Video-based modeling in teaching daily living skills

Autism ? Video-based modeling in teaching daily living skills Occupational Therapy/Autism/Video Modeling/BESt 136 Best Evidence Statement (BESt) Copyright © 2008–2012 Cincinnati Children's Hospital Medical Center; all rights reserved. April 25, 2012 CCHMC Evidence Collaboration: James M. Anderson Center for Health Systems Excellence | Center for Professional Excellence | Edward L. Pratt Research Library Evidence-Based Decision Making (EBDM) LEGEND Resources – http://www.cincinnatichildrens.org (...) /evidence Page 1 of 6 Date: June 21, 2012 Title: The use of Video-Based Modeling in Teaching Daily Living Skills to Children with Autism Clinical Question: P (Population/Problem) In children with autism I (Intervention) does the use of video-based modeling C (Comparison) O (Outcome) improve participation in daily living activities*? Definitions for terms marked with * may be found in the Supporting Information section. Target Population for the Recommendation: Inclusion criteria: Diagnosis of autism

Cincinnati Children's Hospital Medical Center2012

153. Auditory integration training and other sound therapies for autism spectrum disorders (ASD).

Auditory integration training and other sound therapies for autism spectrum disorders (ASD). BACKGROUND: Auditory integration therapy was developed as a technique for improving abnormal sound sensitivity in individuals with behavioural disorders including autism spectrum disorders. Other sound therapies bearing similarities to auditory integration therapy include the Tomatis Method and Samonas Sound Therapy. OBJECTIVES: To determine the effectiveness of auditory integration therapy or other (...) methods of sound therapy in individuals with autism spectrum disorders. SEARCH METHODS: For this update, we searched the following databases in September 2010: CENTRAL (2010, Issue 2), MEDLINE (1950 to September week 2, 2010), EMBASE (1980 to Week 38, 2010), CINAHL (1937 to current), PsycINFO (1887 to current), ERIC (1966 to current), LILACS (September 2010) and the reference lists of published papers. One new study was found for inclusion. SELECTION CRITERIA: Randomised controlled trials involving

Cochrane2011

154. Neuron number and size in prefrontal cortex of children with autism.

Neuron number and size in prefrontal cortex of children with autism. CONTEXT: Autism often involves early brain overgrowth, including the prefrontal cortex (PFC). Although prefrontal abnormality has been theorized to underlie some autistic symptoms, the cellular defects that cause abnormal overgrowth remain unknown. OBJECTIVE: To investigate whether early brain overgrowth in children with autism involves excess neuron numbers in the PFC. DESIGN, SETTING, AND CASES: Postmortem prefrontal tissue (...) from 7 autistic and 6 control male children aged 2 to 16 years was examined by expert anatomists who were blinded to diagnostic status. Number and size of neurons were quantified using stereological methods within the dorsolateral (DL-PFC) and mesial (M-PFC) subdivisions of the PFC. Cases were from the eastern and southeastern United States and died between 2000 and 2006. MAIN OUTCOME MEASURES: Mean neuron number and size in the DL-PFC and M-PFC were compared between autistic and control postmortem

JAMA2011

155. A meta-analytic study on the effectiveness of comprehensive ABA-based early intervention programs for children with autism spectrum disorders

A meta-analytic study on the effectiveness of comprehensive ABA-based early intervention programs for children with autism spectrum disorders A meta-analytic study on the effectiveness of comprehensive ABA-based early intervention programs for children with autism spectrum disorders A meta-analytic study on the effectiveness of comprehensive ABA-based early intervention programs for children with autism spectrum disorders Peters-Scheffer N, Didden R, Korzilius H, Sturmey P CRD summary (...) The authors concluded that comprehensive early intervention behavioural intervention was effective in children with autism spectrum disorders compared with other treatments or usual practice in terms of IQ and adaptive behaviours. The authors' conclusion did not reflect the total evidence presented. Inadequate reporting of the review process means that caution is required when judging the reliability of the review findings. Authors' objectives To evaluate the effectiveness of comprehensive early

DARE.2011

156. Therapies for children with autism spectrum disorders.

Therapies for children with autism spectrum disorders. Therapies for children with autism spectrum disorders. Therapies for children with autism spectrum disorders. Warren Z, Veenstra-VanderWeele J, Stone W, Bruzek JL, Nahmias AS, Foss-Feig JH, Jerome RN, Krishnaswami S, Sathe NA, Glasser AM, Surawicz T, McPheeters ML. Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made (...) for the HTA database. Citation Warren Z, Veenstra-VanderWeele J, Stone W, Bruzek JL, Nahmias AS, Foss-Feig JH, Jerome RN, Krishnaswami S, Sathe NA, Glasser AM, Surawicz T, McPheeters ML.. Therapies for children with autism spectrum disorders. Rockville: Agency for Healthcare Research and Quality (AHRQ). Comparative Effectiveness Review No. 26. 2011 Authors' objectives The Vanderbilt Evidence-based Practice Center systematically reviewed evidence on therapies for children ages 2 to 12 with autism spectrum

Health Technology Assessment (HTA) Database.2011

157. SHANK3, the Synapse, and Autism.

SHANK3, the Synapse, and Autism. SHANK3, the synapse, and autism. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 21751912 Format MeSH and Other Data E-mail Subject Additional text E-mail Add to Clipboard Add (...) to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2011 Jul 14;365(2):173-5. doi: 10.1056/NEJMcibr1104261. SHANK3, the synapse, and autism. 1 . 1 Massachusetts General Hospital and Harvard Medical School, Boston, USA. Erratum in N Engl J Med. 2011 Nov 10;365(19):1848. PMID: 21751912 DOI: [Indexed for MEDLINE] MeSH terms Substances Full Text Sources PubMed Commons 0 comments How to cite this comment: Supplemental Content Full

NEJM2011

158. Intensive behavioral intervention therapy for autism

Intensive behavioral intervention therapy for autism Intensive behavioral intervention therapy for autism Intensive behavioral intervention therapy for autism Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Intensive behavioral intervention therapy for autism. Lansdale: HAYES, Inc.. Directory Publication. 2011 Authors' conclusions Intensive behavioral (...) intervention (IBI) therapy, also known as Lovaas therapy, applied behavior analysis (ABA), or early intensive behavioral intervention (EIBI), is an intensive behavioral treatment program that attempts to improve the cognitive and social functioning of children, primarily young children, with autism. Final publication URL The report may be purchased from: Indexing Status Subject indexing assigned by CRD MeSH Autistic Disorder; Behavior Therapy; Child Behavior; Child Behavior Disorders; Childs Language

Health Technology Assessment (HTA) Database.2011

159. For toddlers with autism spectrum disorders, supplementing a comprehensive intervention with interpersonal synchrony improves socially engaged imitation

For toddlers with autism spectrum disorders, supplementing a comprehensive intervention with interpersonal synchrony improves socially engaged imitation For toddlers with autism spectrum disorders, supplementing a comprehensive intervention with interpersonal synchrony improves socially engaged imitation | Evidence-Based Mental Health This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts (...) OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here For toddlers with autism spectrum disorders, supplementing a comprehensive intervention with interpersonal synchrony improves socially engaged imitation Article Text Therapeutics For toddlers

Evidence-Based Mental Health2011

160. Review: little evidence of clear benefit for most medical treatments for children with autism spectrum disorders

Review: little evidence of clear benefit for most medical treatments for children with autism spectrum disorders Review: little evidence of clear benefit for most medical treatments for children with autism spectrum disorders | Evidence-Based Mental Health This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name (...) or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: little evidence of clear benefit for most medical treatments for children with autism spectrum disorders Article Text Therapeutics Review: little evidence of clear benefit for most medical treatments for children with autism spectrum disorders Statistics from

Evidence-Based Mental Health2011